• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的 Pitt 菌血症评分对预测念珠菌血症患者死亡率的作用:日本一项多中心 7 年回顾性研究。

Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven-year retrospective study conducted in Japan.

机构信息

Department of Respiratory Medicine, Nagasaki University, Nagasaki, Japan.

Division of Respirology, Rheumatology, Infectious Diseases, and Neurology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

出版信息

Mycoses. 2021 Dec;64(12):1498-1507. doi: 10.1111/myc.13380. Epub 2021 Oct 23.

DOI:10.1111/myc.13380
PMID:34655487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9297953/
Abstract

BACKGROUND

Several severity indexes have been reported for critically ill patients. The Pitt bacteremia score (PBS) is commonly used to predict the risk of mortality in patients with bacteraemia.

OBJECTIVES

To develop a scoring system for predicting mortality in candidaemia patients.

METHODS

Medical records at five Japanese tertiary hospitals were reviewed. Factors associated with mortality were analysed using logistic regression modelling. The discriminatory power of scoring models was evaluated by assessing the area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI) and integrated discrimination improvement (IDI).

RESULTS

In total, 422 candidaemia patients were included. Higher PBS, dialysis and retainment of central venous catheter were independent risk factors for all-cause 30-day mortality. However, among the five PBS components, fever was not associated with mortality; therefore, we developed a modified version of the PBS (mPBS) by replacing fever with dialysis. AUC for PBS and mPBS were 0.74 (95% confidence interval [CI]: 0.68-0.80) and 0.76 (95% CI: 0.71-0.82), respectively. The increase in predictive ability of mPBS for 30-day mortality was statistically significant as assessed by NRI (0.24, 95% CI: 0.01-0.46, p = .04) and IRI (0.04, 95% CI: 0.02-0.06, p = .0008). When patients were stratified by mPBS into low (scores 0-3), moderate (4-7) and high risk (≥8), there were significant differences among the survival curves (p < .0001, log-rank test), and 30-day mortality rates were 13.8% (40/290), 36.8% (28/76) and 69.4% (34/49), respectively.

CONCLUSIONS

mPBS can be a useful tool for predicting mortality in candidaemia patients.

摘要

背景

已有多种严重程度指数用于危重症患者。皮特菌血症评分(PBS)常用于预测菌血症患者的死亡风险。

目的

建立一种用于预测念珠菌血症患者死亡率的评分系统。

方法

回顾日本五家三级医院的病历。使用逻辑回归模型分析与死亡率相关的因素。通过评估受试者工作特征曲线下面积(AUC)、净重新分类改善(NRI)和综合判别改善(IDI)来评估评分模型的判别能力。

结果

共纳入 422 例念珠菌血症患者。较高的 PBS、透析和中心静脉导管留置是全因 30 天死亡率的独立危险因素。然而,在 PBS 的五个组成部分中,发热与死亡率无关;因此,我们通过用透析替代发热来修改 PBS(mPBS)。PBS 和 mPBS 的 AUC 分别为 0.74(95%置信区间[CI]:0.68-0.80)和 0.76(95%CI:0.71-0.82)。NRI(0.24,95%CI:0.01-0.46,p=0.04)和 IRI(0.04,95%CI:0.02-0.06,p=0.0008)评估表明,mPBS 对 30 天死亡率的预测能力提高具有统计学意义。当根据 mPBS 将患者分为低危(评分 0-3)、中危(4-7)和高危(≥8)时,生存曲线之间存在显著差异(p<0.0001,对数秩检验),30 天死亡率分别为 13.8%(40/290)、36.8%(28/76)和 69.4%(34/49)。

结论

mPBS 可作为预测念珠菌血症患者死亡率的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add8/9297953/5ed282b0df1f/MYC-64-1498-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add8/9297953/b7872b2cf0e7/MYC-64-1498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add8/9297953/5ed282b0df1f/MYC-64-1498-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add8/9297953/b7872b2cf0e7/MYC-64-1498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/add8/9297953/5ed282b0df1f/MYC-64-1498-g002.jpg

相似文献

1
Modified Pitt bacteremia score for predicting mortality in patients with candidaemia: A multicentre seven-year retrospective study conducted in Japan.改良的 Pitt 菌血症评分对预测念珠菌血症患者死亡率的作用:日本一项多中心 7 年回顾性研究。
Mycoses. 2021 Dec;64(12):1498-1507. doi: 10.1111/myc.13380. Epub 2021 Oct 23.
2
Prognostic factors for candidaemia in intensive care unit patients: a retrospective analysis.重症监护病房患者念珠菌血症的预后因素:一项回顾性分析。
Singapore Med J. 2017 Apr;58(4):196-200. doi: 10.11622/smedj.2016113. Epub 2016 Jun 29.
3
The Pitt Bacteremia Score, Charlson Comorbidity Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection. Pitt 菌血症评分、Charlson 合并症指数和慢性疾病评分是预测念珠菌血流感染患者死亡率的有用工具。
Mycoses. 2017 Oct;60(10):676-685. doi: 10.1111/myc.12644. Epub 2017 Aug 21.
4
Acute kidney injury should not be neglected - optimization of quick Pitt bacteremia score for predicting mortality in critically ill patients with bloodstream infection: a retrospective cohort study.急性肾损伤不容忽视——优化快速皮特菌血症评分以预测重症血流感染患者的死亡率:一项回顾性队列研究
Ther Adv Infect Dis. 2024 Feb 23;11:20499361241231147. doi: 10.1177/20499361241231147. eCollection 2024 Jan-Dec.
5
The combined use of the Charlson Comorbidity Index and National Early Warning Score 2 helps predict the prognosis of candidemia.查尔森合并症指数与国家早期预警评分2的联合使用有助于预测念珠菌血症的预后。
J Infect Chemother. 2025 Jan;31(1):102507. doi: 10.1016/j.jiac.2024.08.022. Epub 2024 Aug 29.
6
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.念珠菌血症和全因死亡率的风险预测模型:一项前瞻性多中心研究。
BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5.
7
Validation of MEDS score in predicting short-term mortality of adults with community-onset bacteremia.验证 MEDS 评分在预测成人社区获得性菌血症短期死亡率中的作用。
Am J Emerg Med. 2020 Feb;38(2):282-287. doi: 10.1016/j.ajem.2019.05.002. Epub 2019 May 3.
8
Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.初始血清(1,3)-β-D-葡聚糖作为确诊念珠菌血症患者死亡率的预测因子:来自意大利和巴西两所教学医院的回顾性研究结果。
Clin Microbiol Infect. 2015 Oct;21(10):954.e9-17. doi: 10.1016/j.cmi.2015.06.002. Epub 2015 Jun 10.
9
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study.肝硬化住院患者念珠菌血症的危险因素:一项多中心病例对照对照研究。
Clin Microbiol Infect. 2021 Feb;27(2):276-282. doi: 10.1016/j.cmi.2020.04.030. Epub 2020 Apr 30.
10
Value of the Pitt Bacteraemia Score to predict short-term mortality in Staphylococcus aureus bloodstream infection: a validation study.匹兹堡菌血症评分对预测金黄色葡萄球菌血流感染短期死亡率的价值:一项验证研究。
Swiss Med Wkly. 2017 Aug 10;147:w14482. doi: 10.4414/smw.2017.14482. eCollection 2017.

引用本文的文献

1
vs. Non- Candidemia in Critically Ill Patients: Clinical Outcomes, Risk Factors, and Mortality.危重症患者念珠菌血症与非念珠菌血症的比较:临床结局、危险因素及死亡率
J Fungi (Basel). 2025 Jul 24;11(8):552. doi: 10.3390/jof11080552.
2
Pitt candidaemia score as an assessment tool for mortality in patients with candidaemia caused by and other species: a multicentre study conducted in Japan.皮特念珠菌血症评分作为评估由白色念珠菌和其他念珠菌属引起的念珠菌血症患者死亡率的工具:一项在日本开展的多中心研究。
JAC Antimicrob Resist. 2025 May 20;7(3):dlaf078. doi: 10.1093/jacamr/dlaf078. eCollection 2025 Jun.
3
and inhibitory effects of the Sanghuang mushroom extracts against .

本文引用的文献

1
Epidemiology of candidemia and impact of infectious disease consultation on survival and care.念珠菌血症的流行病学及感染病会诊对生存和治疗的影响。
Infection. 2020 Apr;48(2):275-284. doi: 10.1007/s15010-020-01393-9. Epub 2020 Feb 12.
2
Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study.念珠菌血症和全因死亡率的风险预测模型:一项前瞻性多中心研究。
BMC Infect Dis. 2019 May 21;19(1):445. doi: 10.1186/s12879-019-4065-5.
3
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
并且桑黄蘑菇提取物对 的抑制作用。
Future Microbiol. 2024;19(11):983-996. doi: 10.1080/17460913.2024.2352269. Epub 2024 Jun 21.
ESICM/ESCMID 工作组关于危重症患者侵袭性念珠菌感染的实际管理。
Intensive Care Med. 2019 Jun;45(6):789-805. doi: 10.1007/s00134-019-05599-w. Epub 2019 Mar 25.
4
Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.快速 Pitt 菌血症评分的推导,以预测革兰氏阴性菌血流感染患者的死亡率。
Infection. 2019 Aug;47(4):571-578. doi: 10.1007/s15010-019-01277-7. Epub 2019 Feb 8.
5
Mortality and risk factor analysis for Candida blood stream infection: A multicenter study.念珠菌血流感染的死亡率及危险因素分析:一项多中心研究。
J Infect Chemother. 2019 May;25(5):341-345. doi: 10.1016/j.jiac.2019.01.002. Epub 2019 Feb 2.
6
Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.日本某大学医院分离出的念珠菌属的抗真菌药敏趋势及耐药机制分析
J Infect Chemother. 2019 Jan;25(1):34-40. doi: 10.1016/j.jiac.2018.10.007. Epub 2018 Nov 3.
7
Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.念珠菌血症患者的临床特征和死亡预测因素:一项六年回顾性研究。
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1717-1724. doi: 10.1007/s10096-018-3304-9. Epub 2018 Jul 20.
8
The Impact of Biofilm Formation on the Persistence of Candidemia.生物膜形成对念珠菌血症持续存在的影响。
Front Microbiol. 2018 Jun 4;9:1196. doi: 10.3389/fmicb.2018.01196. eCollection 2018.
9
[National Trends in the Distribution of Candida Species Causing Candidemia in Japan from 2003 to 2014].[2003年至2014年日本念珠菌血症致病念珠菌属分布的全国趋势]
Med Mycol J. 2018;59(1):E19-E22. doi: 10.3314/mmj.17-00014.
10
The Pitt Bacteremia Score, Charlson Comorbidity Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection. Pitt 菌血症评分、Charlson 合并症指数和慢性疾病评分是预测念珠菌血流感染患者死亡率的有用工具。
Mycoses. 2017 Oct;60(10):676-685. doi: 10.1111/myc.12644. Epub 2017 Aug 21.